Infectious Diseases II

Bacterial Meningitis

de Gans J, van de Beek D; European Dexamethasone

in Adulthood Bacterial Meningitis Study Investigators.

Dexamethasone in adults with bacterial meningitis.

N Engl J Med. 2002;347(20):1549-1556. https://doi.

org/10.1056/nejmoa021334

Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice

guidelines for the management of bacterial meningi-

tis. Clin Infect Dis. 2004;39(9):1267-1284. https://doi.

org/10.1086/425368

Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious

Diseases Society of America’s clinical practice guide-

lines

for

healthcare-associated

ventriculitis

and

meningitis. Clin Infect Dis. 2017;64(6):e34-e65. https://

doi.org/10.1093/cid/ciw861

van de Beek D, Brouwer MC, Koedel U, Wall EC.

2021;398(10306):1171-1183.

https://doi.org/10.1016/

s0140-6736(21)00883-7

van de Beek D, de Gans J, Spanjaard L, Weisfelt M,

Reitsma JB, Vermeulen M. Clinical features and prog-

nostic factors in adults with bacterial meningitis. N Engl

J Med. 2004;351(18):1849-1859. https://doi.org/10.1056/

nejmoa040845

van de Beek D, Drake JM, Tunkel AR. Nosocomial bac-

terial meningitis. N Engl J Med. 2010;362(2):146-154.

https://doi.org/10.1056/nejmra0804573

Antibiotic Stewardship

Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing

an antibiotic stewardship program: guidelines by the

Infectious Diseases Society of America and the Society

for Healthcare Epidemiology of America. Clin Infect

Dis.

2016;62(10):e51-e77.

https://doi.org/10.1093/cid/

ciw118

Kaki R, Elligsen M, Walker S, Simor A, Palmay L,

Daneman N. Impact of antimicrobial stewardship in crit-

ical care: a systematic review. J Antimicrob Chemother.

2011;66(6):1223-1230. https://doi.org/10.1093/jac/dkr137

Wunderink RG, Srinivasan A, Barie PS, et al. Antibiotic

stewardship in the intensive care unit. An official

American Thoracic Society workshop report in col-

laboration with the AACN, CHEST, CDC, and SCCM.

org/10.1513/annalsats.202003-188st

Rapid Diagnostic Tests

August BA, Kale-Pradhan PB, Giuliano C, Johnson

LB. Biomarkers in the intensive care setting: a focus on

using procalcitonin and C-reactive protein to optimize

2023;43(9):935-949. https://doi.org/10.1002/phar.2834

Banerjee R, Teng CB, Cunningham SA, et al.

Randomized trial of rapid multiplex polymerase chain

reaction-based blood culture identification and suscep-

tibility testing. Clin Infect Dis. 2015;61(7):1071-1080.

https://doi.org/10.1093/cid/civ447

Beal SG, Ciurca J, Smith G, et al. Evaluation of the nano-

sphere Verigene gram-positive blood culture assay with

the VersaTREK blood culture system and assessment of

possible impact on selected patients. J Clin Microbiol.

2013;51(12):3988-3992.

https://doi.org/10.1128/

jcm.01889-13

Bloos F, Held J, Kluge S, et al. (1 → 3)-β-D-Glucan-

guided antifungal therapy in adults with sepsis: the

Med.

2022;48(7):865-875.

https://doi.org/10.1007/

s00134-022-06733-x

Bouadma L, Luyt CE, Tubach F, et al. Use of procalcito-

nin to reduce patients’ exposure to antibiotics in intensive

care units (PRORATA trial): a multicentre randomised

doi.org/10.1016/s0140-6736(09)61879-1

Clerc O, Prod’hom G, Vogne C, Bizzini A, Calandra T,

Greub G. Impact of matrix-assisted laser desorption ion-

ization time-of-flight mass spectrometry on the clinical

management of patients with gram-negative bactere-

mia: a prospective observational study. Clin Infect Dis.

2013;56(8):1101-1107. https://doi.org/10.1093/cid/cis1204

de Jong E, van Oers JA, Beishuizen A, et al. Efficacy

and safety of procalcitonin guidance in reducing the

duration of antibiotic treatment in critically ill patients:

Infect Dis. 2016;16(7):819-827. https://doi.org/10.1016/

s1473-3099(16)00053-0

Forrest GN, Mankes K, Jabra-Rizk MA, et al. Peptide

nucleic acid fluorescence in situ hybridization-based

identification of Candida albicans and its impact on

mortality and antifungal therapy costs. J Clin Microbiol.

2006;44(9):3381-3383.

https://doi.org/10.1128/

jcm.00751-06